Complications of percutaneous coronary angioplasty
Journal Title: Polski Przegląd Kardiologiczny - Year 2008, Vol 10, Issue 3
Abstract
Over the last 30 years percutaneous transluminal coronary angioplasty (PTCA) has become the principal way treating coronary artery disease (CAD). With more advanced armamentarium and technical improvements we can observe an expansion of indications for those procedures, despite higher risk in patients with numerous commorbidities. On the other hand it enhances the probability of complications, systemic or local including myocar-dial ischaemia, arrhythmias, coronary artery perforation, cardiac stroke. Experienced invasive cardiologist may quickly diagnose and cure those problems using drugs, intraaortic balloon pump (IABP), stentgrafts etc. However, other general complications, such as contrast induced nephropa-thy (CIN), neurological diseases and major bleedings, postradiation injury are very significant and may affect patient safety and long-term outcomes. Local complications - hemorrhagic effusions, aneurysms, distal embolization, although less serious, have significant implications on in-hospital stay and cost-effectiveness. Therefore, during patient qualification to PTCA and procedure performing we should assess both possible benefits of treatment as well as the possibility of complications, negatively influencing on general outcome.
Authors and Affiliations
Jarosław Rzezak, Piotr Kwiatkowski
Sztywność aorty u chorych z miażdżycą tętnic wieńcowych
Wprowadzenie: Miażdżyca niewątpliwie wpływa na funkcję ściany tętnic, a podwyższony poziom cholesterolu uważany jest za czynnik zmniejszający ich elastyczność. Cel pracy: Ocena sztywności aorty (aortic stiffness - SA) u...
Stable angina - what's the new in European Society of Cardiology guidelines?
New guidelines on the management of stable angina pectoris have been recently published by theTask Force of the European Society of Cardiology updating previous document from the year 1997. The guidelines indicate on the...
The role of elective coronary bypass grafting early after acute myocardial infarction in patients initially treated with primary percutaneous coronary intervention
Introduction: It is well established that percutaneous coronary inten/ention (PCI) in the first hours after acute myocardial infarction (AMI) is the optimal treatmentoption. This procedure minimizes necrosis, leading to...
Znaczenie markera NGAL w diagnostyce powikłań nerkowych w przebiegu chorób kardiologicznych
Wprowadzenie do diagnostyki nowych biomarkerów uszkodzenia kanalików nerkowych: NGAL (neutrophil gelatinase associated lipocalin), KIM-1 (kidney injury molecule-1), bogatego w cysteinę białka 61, cystatyny C, interleukin...
Nowe aspekty w farmakologii receptorów β-adrenergicznych w niewydolności mięśnia sercowego
Antagoniści receptorów β-adrenergicznych (β-AR) (niespecyficzni bądź receptorów β1-AR) stanowią podstawę standardowej terapii przewlekłej niewydolności mięśnia sercowego. Ich celem jest zapobieganie skutkom typowej dla t...